U.S. Finalises Exit from WHO, Pulling 15% of Agency Budget

Great-power walk-outs from multilateral bodies are not new: the U.S. quit UNESCO in 1984, only to re-enter in 2003 and depart again in 2017 before rejoining in 2023. Each exit created funding vacuums quickly filled by other actors—chiefly the EU, Japan and, more recently, China—shifting soft-power balances. The 2026 WHO departure fits a longer arc of American retrenchment from post-1945 institutions amid domestic scepticism of global governance, a trend mirrored by Brexit and China’s parallel institution-building (AIIB, BRI health corridors). In the near term, programmes like polio eradication that depend on earmarked U.S. dollars face disruption; over decades, persistent underfunding could accelerate a two-tier global health architecture where private philanthropies and regional blocs, rather than a universal agency, set priorities. Whether the U.S. return cycle repeats—or rivals step permanently into the gap—will colour the legitimacy of the post-war health regime well into the late 21st century.